Delays in treatment for psychosis can be associated with poorer outcomes.
While lithium has been the mainstay of treatment for decades, several other classes of medication have recently been used with varying degrees of success.
Atypical antipsychotic adjunctive therapy to mood stabilizers may be more effective than mood stabilizer monotherapy.
For the acute treatment of manic or mixed episodes in bipolar I disorder, the recommended starting and treatment dose is now 5-10mg twice daily.
This study included Medicaid patients taking medications to treat bipolar disorder, schizophrenia, or major depression with psychosis.
Lithium prescription rates for patients with bipolar disorder have declined during the last decade.
Group psychoeducation is a low-cost psychological intervention with specific clinical benefits in early bipolar disorder, if the focus of care is preventing future mania relapse and improving self-management, interpersonal function, and support.
The Mood Zoom questionnaire asks users to rate anxiety, elation, sadness, anger, irritability, and energy on a 7-point Likert scale
Programs conducted in early stages of bipolar disorder to improve cognition and functioning may boost cognitive reserve and thus, help prevent cognitive decline.
One line of future research in this area will be examining whether dorsal attention network connectivity predicts behavioral performance and emotional reactivity.
Psychiatry Advisor Articles
- Sleep Disorders: How to Manage Headaches in Patients?
- Anxiety and ADHD in Patients With Single-Ventricle Congenital Heart Disease
- Alcohol Use Disorder Diagnosis Stable From DSM-IV to DSM-5
- Opioid Cravings Reduced by Medication from ER Visits
- Neuropsychiatric Symptoms in Patients With HCV Cured of Infection
- Naltrexone-Assisted Detox vs Buprenorphine Taper for Opioid Dependence
- Pediatric Patients Should Undergo Electrocardiogram Assessment Before Antipsychotic Treatment
- Best Practices for Treatment of Bipolar Disorder
- Health Effects and Therapeutic Benefits of Cannabis
- Benzodiazepines Increase Stroke Risk in Alzheimer's